Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share

Breast Cancer News


Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine... Continue Reading

OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine (August 13, 2014)

Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex®... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who... Continue Reading

Tykerb and Herceptin Combination Therapy Fails to Improve Outcomes for Early Stage HER2 Breast Cancer (June 10, 2014)

Dr. Martine Piccart-Gebhart presented results at the 2014 annual meeting of the American Society of Clinical Oncology showing that a combination treatment of Tykerb® (lapatinib) and Herceptin® (trastuzumab)... Continue Reading

Multiple Studies Presented at ASCO® Annual Meeting Demonstrate Unique, Practice-Changing Impact of Oncotype DX® to Optimize Cancer Care (June 9, 2014)

New Study Shows Oncotype DX® DCIS Score™ Changes Treatment Recommendations for One Out of Three DCIS Patients Fifth Direct Comparison Study Confirms Oncotype DX, the Only Test Shown to Predict Chemotherapy... Continue Reading

Updated Guidelines for Adjuvant Tamoxifen in Hormone-Positive Breast Cancer (May 29, 2014)

The American Society of Clinical Oncology (ASCO) has updated their guidelines for the use of adjuvant endocrine therapy, particularly adjuvant tamoxifen (Nolvadex®), for women with hormone receptor-positive... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers... Continue Reading

More Breast Cancer News

Latest Breast Cancer News By Stage


Screening and Prevention

Weighing the Risks (August 12, 2014)

Exploring the Link Between Obesity and Cancer By Kari Bohlke, ScD “For the great majority of Americans who do not use tobacco, weight control, dietary choices, and levels of physical activity are the most important modifiable determinants of cancer... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Regular Physical Activity Reduces Risk of Breast Cancer (April 28, 2014)

An hour of daily physical activity reduces the risk of breast cancer, regardless of age or weight, according to the results of a study presented at the 2014 European Breast Cancer Conference in Glasgow, Scotland. Each year, roughly 227,000 women are diagnosed... Continue Reading

Reduced Mammography Screening for Breast Cancer Translates to Billions in Savings (February 18, 2014)

Reducing mammography screening frequency from annually to biennially among women aged 50 to 74 could save the healthcare system billions of dollars annually—and may actually allow physicians to end up screening more women compared with the current practice,... Continue Reading

Arimidex May Prevent Breast Cancer in High-Risk Women (January 7, 2014)

Arimidex® (anastrozole) reduced the risk of breast cancer by 53 percent in high-risk postmenopausal women, according to the results of a study presented at the 2013 San Antonio Breast Cancer Symposium and published simultaneously online in The Lancet. Arimidex... Continue Reading

More Screening and Prevention

Carcinoma in Situ

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Tykerb and Herceptin Combination Therapy Fails to Improve Outcomes for Early Stage HER2 Breast Cancer (June 10, 2014)

Dr. Martine Piccart-Gebhart presented results at the 2014 annual meeting of the American Society of Clinical Oncology showing that a combination treatment of Tykerb® (lapatinib) and Herceptin® (trastuzumab) offered no benefit in outcomes for early stage... Continue Reading

Multiple Studies Presented at ASCO® Annual Meeting Demonstrate Unique, Practice-Changing Impact of Oncotype DX® to Optimize Cancer Care (June 9, 2014)

New Study Shows Oncotype DX® DCIS Score™ Changes Treatment Recommendations for One Out of Three DCIS Patients Fifth Direct Comparison Study Confirms Oncotype DX, the Only Test Shown to Predict Chemotherapy Benefit, is Different from Other Multi-Gene... Continue Reading

More Carcinoma in Situ

Stage I - Node Negative

Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine demonstrate that Aromasin® (exemestane), is... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

More Stage I Node Negative

Stages II-III

Aromasin is New Treatment Option for Young Women With Hormone-sensitive Breast Cancer (August 19, 2014)

The results of a recently completed clinical study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and now published online in the New England Journal of Medicine demonstrate that Aromasin® (exemestane), is... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Aromasin Reduces Risk of Recurrence in Early Breast Cancer (June 25, 2014)

In a joint analysis of two clinical trials reported at the American Society of Clinical Oncologists meeting in Chicago, researchers found that premenopausal women undergoing hormone suppression and who were treated with Aromasin® (exemestane) had reduced... Continue Reading

More Stages II and III

Inflammatory

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Multiple Studies Presented at ASCO® Annual Meeting Demonstrate Unique, Practice-Changing Impact of Oncotype DX® to Optimize Cancer Care (June 9, 2014)

New Study Shows Oncotype DX® DCIS Score™ Changes Treatment Recommendations for One Out of Three DCIS Patients Fifth Direct Comparison Study Confirms Oncotype DX, the Only Test Shown to Predict Chemotherapy Benefit, is Different from Other Multi-Gene... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Dana-Farber Expert Answers Questions about Breast Cancer, Diet and Exercise (April 25, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

More Inflammatory

Metastatic

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Dana-Farber Expert Answers Questions about Breast Cancer, Diet and Exercise (April 25, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan... Continue Reading

Mastectomy May Be Unnecessary in Stage IV Breast Cancer (March 13, 2014)

Mastectomy is unnecessary in many women with stage IV breast cancer—and in fact may even facilitate the spread of the disease, according to the results of a study presented at the 2013 San Antonio Breast Cancer Symposium. Mastectomy—surgical removal... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

Higher Dose of Faslodex Effective in Advanced Breast Cancer (December 30, 2013)

The final results are in—and they show that 500 mg of Faslodex® (fulvestrant) provides a significant advantage in overall survival compared to 250 mg of the drug in postmenopausal women with locally advanced or metastatic estrogen receptor–positive... Continue Reading

More Metastatic

Recurrent

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Dana-Farber Expert Answers Questions about Breast Cancer, Diet and Exercise (April 25, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan... Continue Reading

New Breast Cancer Surgical Guidelines (February 28, 2014)

The Society of Surgical Oncology and the American Society for Radiation Oncology have announced new surgical guidelines indicating that although negative margins (no ink on tumor) reduce the risk of local recurrence, wider margin widths do not significantly... Continue Reading

Reconstructive Breast Surgery On the Rise, but Influenced By Location (February 24, 2014)

More women are choosing reconstructive breast surgery after mastectomy; however, there is a large variation in the rate of reconstructive surgery throughout different areas of the United States, according to the results of a study published early online... Continue Reading

More Recurrent

Supportive Care

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Dana-Farber Expert Answers Questions about Breast Cancer, Diet and Exercise (April 25, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan... Continue Reading

Compression Bandage As Effective As Lymphatic Massage for Lymphedema (December 13, 2013)

Lymphatic massage is no better than compression bandages for the treatment of lymphedema, according to the results of a study published in the Journal of Clinical Oncology. Lymphedema is the buildup of lymph fluid in the tissues just under the skin, resulting... Continue Reading

Question and Answer Session with Dana-Farber Breast Cancer Experts (October 24, 2013)

CancerConnect recently partnered with Dana-Farber Cancer Institute’s Susan F. Smith Center for Women’s Cancers to provide you with the opportunity to engage with breast cancer experts Harold J. Burstein, MD, PhD, and Erica L. Mayer, MD, MPH, who answered... Continue Reading

More Supportive Care

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS